As an institution receiving funding from the National Institutes of Health (NIH), WSU is subject to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.
Risk Group 2 (RG2) agents are associated with human disease for which preventative or therapeutic interventions are often available.
All research subject to the NIH Guidelines or with RG2 agents requires review by the IBC.
The IBC is transitioning to an online submission process (eProtocol). Please contact the WSU Biosafety Manager to determine whether you should submit via e-protocol or through the traditional application route.
Protocols for work including US Army Funded Research using cadaveric materials, or applications for work with inactivated high risk agents is not currently integrated into the eProtocol system. Forms required for these types of application can be found below and should be submitted via e-mail to the WSU Biosafety Manager.
Regardless of the application type, approvals are valid for three (3) years from the initial review/approval process and apply only to the lab originally inspected and the investigator originally approved.
If you have a current, approved protocol that is on the old Word application form, you do not need to use eProtocol at this time. You can submit amendments to these protocols using the Word documents below.
If it is determined that e-protocol is to be used for your application, please follow the information below.
A Division of Research eProtocol website with training manuals and a link to eProtocol can be found at http://research.wayne.edu/eprotocol/.
You can access eProtocol directly at https://ksprodweb.ovpr.wayne.edu/.
- Please make sure you use the latest version of one of the supported browsers: Firefox or Safari
eProtocol Frequently Asked Questions (FAQs)
Protocol Application Questions
If directed by the Biosafety Manager, please use the IBC Biological Agent User Application form documents for your IBC application.
The following types of IBC applications are stand-alone application forms and are not currently merged with the e-protocol format. Please submit electronic copies of these documents to the WSU Biosafety Manager.
- All research activity that is being supported by grants from the US Army and involve the use of cadaveric material must obtain approval from the WSU IBC.
- Research groups or core facilities that plan on receiving inactivated high risk biological agents must obtain prior approval from the WSU IBC.
If you have a currently approved protocol that is not via eProtocol and wish to alter the research procedures, add a new agent, move to a new location, or hire new employees to work on the IBC approved projects, then you are required to submit a Protocol Amendment Form.
If you are unsure if an amendment is required, please contact the WSU Biosafety Manager.